| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| omalizumab | high affinity immunoglobulin epsilon receptor subunit alpha | biotech | NA | drugbank , DGIDB | Asthma[MeSHID:D001249] Inspiration function[MeSHID:D001239] Urticaria[MeSHID:D014581] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
28.29 | approved,investigational | inhibitor |
| omalizumab | immunoglobulin epsilon fc receptor gamma | NA | Successful target | TTD | Asthma[MeSHID:D001249] Inspiration function[MeSHID:D001239] Urticaria[MeSHID:D014581] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | unknown |
| omalizumab | high affinity immunoglobulin epsilon receptor subunit beta | biotech | NA | drugbank , DGIDB | Asthma[MeSHID:D001249] Inspiration function[MeSHID:D001239] Urticaria[MeSHID:D014581] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
106.09 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||